Business description
Gedeon Richter Plc., headquartered in Budapest/Hungary, is a major pharmaceutical company in Central Eastern Europe, with an expanding direct presence in Western Europe. The product portfolio of Richter covers almost all important therapeutic areas, including gynaecology, central nervous system, and cardiovascular areas. Having the largest R&D unit in Central Eastern Europe, Richter's original research activity focuses on CNS disorders. With its widely acknowledged steroid chemistry expertise, Richter is a significant player in the female healthcare field worldwide. Richter is also active in biosimilar product development.
Management board & Supervisory board
| CEO |
| Gabor Orban |
| Management board |
| István Hamecz, Katalin Erdei, Dr István Greiner, Tibor Horváth, Attila Szénási, Tamás Szolyák |
| Supervisory board |
| Prof Dr Szilveszter E. Vizi, Dr Ilona Hardy dr Pintérné, Erik Bogsch, Gábor Orbán, Dr Nándor Pál Ács, Gabriella Balogh, István Hamecz, Dr Péter Cserháti, Mrs Lászlóné Németh, Dr Anett Pandurics, Bálint Szécsényi, Balázs Szepesi, Dr Attila Chikán, Dr Róbert Jonathán Bedros, Dr Krisztina Gál, Dr Zoltán Matos, Dr Lívia Pavlik, Ferenc Sallai |
Company data
| Name: |
Chemical Works of Gedeon Richter PLC |
| Address: |
Gyömroi út 19-21.,HU-1103 Budapest |
| Phone: |
+(36) 1-431-4000 |
| Fax: |
+(36) 1-260-6650 |
| E-mail: |
investor.relations@richter.hu
|
| Internet: |
https://www.gedeonrichter.com/en/ |
| Industry: |
Healthcare |
| Sector: |
Pharmaceutical Industry |
| Sub sector: |
- |
| End of financial year: |
12-31 |
| Free Float: |
74.93% |
| IPO date: |
1994-11-09 |
